These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1773028)

  • 1. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft platelet activating factor synthesis during acute cellular rejection.
    Mangino MJ; Anderson CB; Murphy MK; Turk J
    J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
    Bito H; Kudo Y; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor in human normal tears.
    Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB; Lam MH; Hsu AH
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of platelet-activating factor to oviductal membranes during early pregnancy in the rabbit.
    Yang YQ; Kudolo GB; Harper MJ
    J Lipid Mediat; 1992 Feb; 5(1):77-96. PubMed ID: 1391740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ; Murphy MK; Weiss A; Anderson CB
    J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
    Hwang SB; Wang S
    Mol Pharmacol; 1991 Jun; 39(6):788-97. PubMed ID: 2051992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophils.
    Paulson SK; Nicholson NS
    J Immunol Methods; 1988 Jun; 110(2):209-15. PubMed ID: 2837517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor-induced aggregation of rat alveolar macrophages.
    Rabovsky J; Goddard M; Pailes WH; Judy DJ; Castranova V
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):163-72. PubMed ID: 2396044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor biosynthesis and degradation in rat glomeruli.
    Zanglis A; Lianos EA
    J Lab Clin Med; 1987 Sep; 110(3):330-7. PubMed ID: 3611955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
    Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
    Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.